In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration
Open Access
- 15 January 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 696
Abstract
Hepatic fibrosis (HF) is an important pathological state in the progression of chronic liver disease to end-stage liver disease and is usually triggered by alcohol, nonalcoholic fatty liver, chronic hepatitis viruses, autoimmune hepatitis (AIH), or cholestatic liver disease. Research on novel therapies has become a hot topic due to the reversibility of HF. Research into the molecular mechanisms of the pathology of HF and potential drug screening relies on reliable and rational biological models, mainly including animals and cells. Hence, a number of modeling approaches have been attempted based on human dietary, pathological, and physiological factors in the development of HF. In this review, classical and novel methods of modeling HF in the last 10 years were collected from electronic databases, including Web of Science, PubMed, ScienceDirect, ResearchGate, Baidu Scholar, and CNKI. Animal models of HF are usually induced by chemical toxicants, special diets, pathogenic microorganisms, surgical operations, and gene editing. The advantages and limitations of hepatic stellate cells (HSCs), organoids, and 3D coculture-based HF modeling methods established in vitro were also proposed and summarized. This information provides a scientific basis for the discovery of the pathological mechanism and treatment of HF.Keywords
Funding Information
- National Natural Science Foundation of China (82174083, 2402401026, 2024zd026, 2024CXTD16)
- Fundamental Research Funds for the Central Universities (82174083, 2402401026, 2024zd026, 2024CXTD16)
- Sichuan Provincial Administration of Traditional Chinese Medicine (82174083, 2402401026, 2024zd026, 2024CXTD16)
- Scientific and Technological Innovation Team for Qinghai–Tibetan Plateau Research at Southwest Minzu University (82174083, 2402401026, 2024zd026, 2024CXTD16)
This publication has 129 references indexed in Scilit:
- The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver FibrosisAdvanced Materials, 2023
- In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell lineBiotechnology and Bioengineering, 2023
- Rhesus rotavirus receptor‐binding site affects high mobility group box 1 release, altering the pathogenesis of experimental biliary atresiaHepatology Communications, 2022
- In vitro modeling of liver fibrosis in 3D microtissues using scalable micropatterning systemArchives of Toxicology, 2022
- Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance ImagingJournal of Magnetic Resonance Imaging, 2021
- Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?Hepatology, 2021
- Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent modelsJournal of Molecular Medicine, 2020
- A Rotavirus-Induced Mouse Model to Study Biliary Atresia and Neonatal Cholestasis2019
- Experimental models of liver fibrosisArchives of Toxicology, 2015
- Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cellsHepatology, 2006